WMT

115.49

-1.11%↓

PG

145.33

+0.13%↑

KO

70.46

-0.75%↓

PM

158.28

-0.06%↓

PEP

150.45

-0.52%↓

WMT

115.49

-1.11%↓

PG

145.33

+0.13%↑

KO

70.46

-0.75%↓

PM

158.28

-0.06%↓

PEP

150.45

-0.52%↓

WMT

115.49

-1.11%↓

PG

145.33

+0.13%↑

KO

70.46

-0.75%↓

PM

158.28

-0.06%↓

PEP

150.45

-0.52%↓

WMT

115.49

-1.11%↓

PG

145.33

+0.13%↑

KO

70.46

-0.75%↓

PM

158.28

-0.06%↓

PEP

150.45

-0.52%↓

WMT

115.49

-1.11%↓

PG

145.33

+0.13%↑

KO

70.46

-0.75%↓

PM

158.28

-0.06%↓

PEP

150.45

-0.52%↓

Search

USANA Health Sciences Inc

Uždarymo kaina

20.23 -0.64

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

20.01

Max

20.63

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-17M

-6.7M

Pardavimai

-22M

214M

P/E

Sektoriaus vid.

21.567

28.852

Pelnas, tenkantis vienai akcijai

-0.15

Pelno marža

-3.118

Darbuotojai

1,700

EBITDA

-17M

11M

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

+90.9% upside

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-27M

355M

Ankstesnė atidarymo kaina

20.87

Ankstesnė uždarymo kaina

20.23

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bullish Evidence

USANA Health Sciences Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-12-16 23:46; UTC

Rinkos pokalbiai

Gold Edges Higher, Aided by Fed Rate-Cut Prospects -- Market Talk

2025-12-16 23:38; UTC

Rinkos pokalbiai

Nikkei May Rise on Possible Bargain-Hunting Interest -- Market Talk

2025-12-16 22:35; UTC

Įsigijimai, susijungimai, perėmimai

Santos: Sale Delivered Cash, Reduced Future Decommissioning Exposure

2025-12-16 22:35; UTC

Įsigijimai, susijungimai, perėmimai

Santos Sold 43% Stake in Petrel Fields, 100% of Tern Fields to Eni Australia

2025-12-16 22:33; UTC

Įsigijimai, susijungimai, perėmimai

Santos: A$40M Upfront Consideration, Up to A$20M in Contingent Payments

2025-12-16 22:33; UTC

Įsigijimai, susijungimai, perėmimai

Santos Sold 43% Operated Interest in Mahalo JV to Comet Ridge

2025-12-16 22:32; UTC

Įsigijimai, susijungimai, perėmimai

Santos Divests Two Noncore Assets as Part of Portfolio Optimization

2025-12-16 22:25; UTC

Įsigijimai, susijungimai, perėmimai

Westgold's Indicative Timetable Points to Early February Completion

2025-12-16 22:24; UTC

Įsigijimai, susijungimai, perėmimai

Westgold: Divestment Aligns With Broader Corporate Strategy

2025-12-16 22:23; UTC

Įsigijimai, susijungimai, perėmimai

Westgold: Deferred Payment Based on Performance Hurdles

2025-12-16 22:23; UTC

Įsigijimai, susijungimai, perėmimai

Westgold Will Receive A$15M Cash, A$19.6M in Alicanto Shares

2025-12-16 22:23; UTC

Įsigijimai, susijungimai, perėmimai

Westgold to Receive A$30M Deferred Payment in Cash or Shares

2025-12-16 22:22; UTC

Įsigijimai, susijungimai, perėmimai

Westgold Divesting Noncore Operating Asset for A$64.6M

2025-12-16 22:22; UTC

Įsigijimai, susijungimai, perėmimai

Westgold Agrees to Sell Mt Henry-Selene Project to Alicanto Minerals

2025-12-16 21:53; UTC

Uždarbis

Lennar Misses Earnings Estimates. The Stock Is Dropping. -- Barrons.com

2025-12-16 21:50; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2025-12-16 21:33; UTC

Įsigijimai, susijungimai, perėmimai

Warner Preparing to Tell Shareholders to Reject Paramount Offer -- 2nd Update

2025-12-16 21:18; UTC

Įsigijimai, susijungimai, perėmimai

Warner Preparing to Tell Shareholders to Reject Paramount Offer -- Update

2025-12-16 21:17; UTC

Įsigijimai, susijungimai, perėmimai

Worthington Enterprises to Buy LSI Group for About $205M >WOR

2025-12-16 21:16; UTC

Uždarbis

Worthington Enterprises 2Q Sales $327.5M >WOR

2025-12-16 21:16; UTC

Uždarbis

Worthington Enterprises 2Q Adj EPS 65c >WOR

2025-12-16 21:16; UTC

Uždarbis

Worthington Enterprises 2Q EPS 55c >WOR

2025-12-16 21:15; UTC

Įsigijimai, susijungimai, perėmimai

Worthington Enterprises Agrees To Acquire Leading Metal Roof Components Manufacturer LSI Group >WOR

2025-12-16 21:05; UTC

Įsigijimai, susijungimai, perėmimai

Ecolab Closes Acquisition Of Ovivo's Electronics Ultrapure Water Business >ECL

2025-12-16 20:54; UTC

Įsigijimai, susijungimai, perėmimai

Warner to Reject Paramount Offer As Soon As Wednesday, Sources Say -- WSJ

2025-12-16 20:54; UTC

Įsigijimai, susijungimai, perėmimai

Warner Preparing to Tell Shareholders to Reject Paramount Offer -- WSJ

2025-12-16 20:54; UTC

Įsigijimai, susijungimai, perėmimai

Warner to Recommend Existing Netflix Deal, Sources Say -- WSJ

2025-12-16 20:44; UTC

Rinkos pokalbiai

Russia-Ukraine Peace Efforts Send Crude to Near 5-Year Low -- Market Talk

2025-12-16 20:04; UTC

Rinkos pokalbiai

U.S. Natural Gas Extends Weather-Driven Losing Streak -- Market Talk

2025-12-16 20:01; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

Akcijų palyginimas

Kainos pokytis

USANA Health Sciences Inc Prognozė

Kainos tikslas

By TipRanks

90.9% į viršų

12 mėnesių prognozė

Vidutinis 39 USD  90.9%

Aukščiausias 39 USD

Žemiausias 39 USD

Remiantis 1 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines USANA Health Sciences Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

1 ratings

0

Pirkti

1

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

28.405 / 29.84Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Weak Bullish Evidence

Vidutinės trukmės periodas

Bullish Evidence

Ilgalaikis periodas

No Evidence

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę USANA Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
help-icon Live chat